Authors
Yaqi Yang, Xiaoxiao Liu, Junqiang Ding, Jinliang Xu, Jianhua Zhang, Hanchang Zhang, Rong Yang, Sha Li, Lu Zheng, Runping Su, Yue Zhao, Jianxiao Wu, Hao Li, Changyou Zhan, Xihui Gao
Published in
Advanced science (Weinheim, Baden-Wurttemberg, Germany). Pages e77691. Sep 16, 2026. Epub Sep 16, 2026.
Abstract
The immunosuppressive microenvironment limits immunotherapy in triple-negative breast cancer (TNBC). Interleukin-15 (IL-15) activates cytotoxic lymphocytes but is limited by rapid clearance and poor tumor retention. Here, we developed an oncolytic adenovirus encoding IL15C-CBD, an immunocytokine comprising an IL-15/IL-15Rα sushi-domain complex fused to a collagen-binding domain, thereby establishing a self-reinforcing immunostimulatory milieu within tumors. Intratumoral administered OV-IL15C-CBD lyses tumor cells and secretes IL15C-CBD that anchors to extracellular matrix collagens, forming a localized cytokine reservoir. In the murine 4T1 TNBC model, this strategy profoundly remodeled the microenvironment by recruiting CD8+ T cells and natural killer cells, depleting regulatory T cells, and polarizing macrophages. toward an M1-like phenotype. Consequently, OV-IL15C-CBD induced significant tumor regression and extended survival without evident systemic toxicity. This therapeutic advantage was further validated in the EMT6 breast tumor model, yielding consistent antitumor efficacy and prolonged survival. Collectively, anchoring immunocytokines to the tumor stroma via oncolytic viruses provides a potentially safe and effective localized immunotherapy for TNBC.
PMID:
42747203
Bibliographic data and abstract were imported from PubMed on 16 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 36
- Comments 0